Joel Greenblatt’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.04M Buy
22,545
+5,673
+34% +$481K ﹤0.01% 1141
2026
Q1
$1.41M Buy
16,872
+11,587
+219% +$951K ﹤0.01% 1208
2025
Q4
$484K Sell
5,285
-31,535
-86% -$3.02M ﹤0.01% 1450
2025
Q3
$3.49M Buy
36,820
+20,170
+121% +$1.9M 0.02% 866
2025
Q2
$1.74M Buy
+16,650
New +$1.58M 0.01% 968
2024
Q4
Sell
-17,596
Closed -$1.44M 1463
2024
Q3
$1.44M Buy
17,596
+13,886
+374% +$1.07M 0.01% 822
2024
Q2
$320K Buy
+3,710
New +$300K ﹤0.01% 1211
2024
Q1
Sell
-18,274
Closed -$1.21M 1414
2023
Q4
$1.21M Buy
18,274
+3,170
+21% +$220K 0.02% 741
2023
Q3
$1.1M Buy
+15,104
New +$1.02M 0.02% 742
2020
Q1
Sell
-17,477
Closed -$1.29M 1131
2019
Q4
$1.29M Sell
17,477
-96,617
-85% -$6.03M 0.02% 574
2019
Q3
$6.52M Buy
114,094
+46,457
+69% +$3.08M 0.12% 232
2019
Q2
$4.42M Buy
+67,637
New +$4.71M 0.07% 341

Other funds holding HQY

Joel Greenblatt's HQY Position: Q2 2026 in Review

Joel Greenblatt increased its HealthEquity (HQY) stake by 34% in Q2 2026, buying an estimated $481K and bringing the position to 22,545 shares worth $2.04M. The position accounts for ﹤0.01% of the portfolio, ranked #1141.

Joel Greenblatt first reported a position in HQY in Q2 2019 and has held it in 12 quarters since. The position peaked at $6.52M in Q3 2019. 495 funds tracked by Wall St. Rank hold HQY as of Q2 2026.

  • Joel Greenblatt held 22,545 shares of HealthEquity worth $2.04M as of Q2 2026.
  • Joel Greenblatt bought 5,673 HealthEquity shares in Q2 2026, an estimated $481K.
  • HealthEquity made up ﹤0.01% of Joel Greenblatt's portfolio in Q2 2026, its #1141 holding.
  • Joel Greenblatt first reported a position in HealthEquity in Q2 2019 and has held it in 12 quarters since.
  • Joel Greenblatt's HealthEquity position peaked at $6.52M in Q3 2019.
  • 495 funds tracked by Wall St. Rank held HealthEquity as of Q2 2026.

Based on Gotham Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.